Ligand Pharmaceuticals Incorporated

US$306.20As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LGNDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 17.32%
Div yield —
ROE 5.38%
Biotechnology
Beta (5Y) 1.03
PE TTM 128.0
TSR TTM 60.05%
Mkt cap US$6.125B
ROIC 2.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$372
21.59%
95.14%
Hold 5|4|11|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
3.55
3.90
3.98
4.03
10.17%
18.14%
25.82%
14.07%
Revenue$M
595.1
595.9
629.4
631.9
11.28%
11.67%
16.28%
10.82%
Peers (US$6.125B)
Cap (US$)
PE
6.210B
—
6.306B
—
Capital
TTM
5Y
10Y
Leveragex
0.898
2.170
1.726
EBIT/Intx
5.205
0.289
0.282
Own earn%
36.85
(20.80)
(22.95)
Sh yield%
40.78
10.65
9.81
Owners
Insiders/Inst%
2.48
74.42
Short interest%
4.60
SBC / revenue%
2.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
22–32
$1 testx
—
Incr. ROIC%
1